Search Main menu Skip to primary content Skip to secondary content About Aurovitas About us Where we are Pharmacovigilance Products Generic drugs Decubal Press room Join Aurovitas Work for us Contact ABOUT US Welcome to Aurovitas , Since April 1, 2014, the company Actavis Spain has been acquired by the Aurobindo Group and is renamed Aurovitas. Aurovitas will continue to market the Actavis product portfolio in the Spanish market, made up of: Brands, generics and OTC, thus covering key therapeutic groups such as Central Nervous System, Cardiovascular, Dermatology and Digestive, among others. From now on, as before, our commitment to healthcare professionals is maximum, training and supporting them so that their daily work and access to the health of their patients is easier. Aurovitas will continue to offer you the highest quality products; the people who take care of you, the processes, the systems ... do not change, we continue to be oriented to offer the best possible service to you and your patients. PRESS ROOM Aurobindo acquires Actavis business in seven European countries 07/19/2014 Aurobindo acquires Actavis business in seven European countries ... PRODUCT PORTFOLIO SPECIALIST DES INJECTABLE PRODUCTS In notre qualité de spécialiste in injectable products, nous proposons a large éventail d'oncolytiques de haute qualité à des prix accessible CAPECITABINE ACTAVIS 150 mg and 500 mg, pellicule tablets Capecitabine is available exclusively sur ordonnance. Home Inner Aurovitas Spain SA Avenida de Burgos 16 D, 5th floor, Euromor Building 28036 Madrid Tel: +34 91 630 86 45 Fax: +34 91 630 26 64 web: www.aurovitas.es © Copyright 2014 Aurovitas Web map